NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Ellen G. Feigal, MD

Practice Area Focus

  • Development Strategy
  • Clinical Study Design
  • Pharmaceuticals
  • Biologics
  • Cell therapies
  • Orphan Drugs
  • Medical Imaging

Biography

Dr. Feigal is a Partner in NDA Partners. She was formerly Senior Vice President of Research and Development at the California Institute for Regenerative Medicine; Executive Medical Director, Global Development, at Amgen; and Chief Medical Officer at Insys Therapeutics. Dr. Feigal was a founding Director of the American Course on Drug Development and Regulatory Sciences. The course was developed under her leadership as a collaborative effort with the FDA, UC San Francisco's Department of Bioengineering and Therapeutic Sciences, its Center for Drug Development Sciences, and the European Center of Pharmaceutical Medicine at the University of Basel. She has worked in clinical research and product development in positions at the Federal Government and non-profit institutes including Director of Medical Devices and Imaging at the Critical Path Institute, and Vice President of Clinical Sciences and Deputy Scientific Director at the Translational Genomics Research Institute. She directed the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis after serving as Deputy Director, and was a senior investigator in the Cancer Therapy Evaluation Program. Dr. Feigal earned an MD at UC Davis, completed an internal medicine residency at Stanford, and a hematology/oncology fellowship at UC San Francisco. She was on the faculty at UC San Francisco, and UC San Diego, before joining the NCI.